GLP-1 vs Orlistat: How the Two Compare
A fair look at a decades-old fat blocker next to today's appetite-focused GLP-1 medications: how they differ, what the evidence shows, and who each may suit.
If you have looked into weight-loss medication, you have probably run into two very different options with very different reputations. Orlistat has been around for decades, and you can buy a version of it off the shelf. GLP-1 medications are newer, come as a weekly injection, and get most of the headlines. Patients ask us all the time whether the older, cheaper pill is good enough, or whether the injection is worth the extra cost and effort. The honest answer starts with a fact that surprises people: these two are not doing the same job in your body at all.
They work on completely different systems
Orlistat is a fat blocker. It works right inside your gut, where it partially shuts down the enzymes (lipases) that break dietary fat into pieces small enough to absorb. When that fat cannot be broken down, it passes through instead of being stored, and orlistat blocks roughly 30% of the fat in a given meal. It barely enters your bloodstream; nearly all of its action happens locally in the digestive tract. Notably, it does nothing to change how hungry you feel.
GLP-1 medications work on the opposite end of the problem: appetite. Semaglutide (sold as Ozempic and Wegovy by Novo Nordisk) and tirzepatide (sold as Mounjaro and Zepbound by Eli Lilly; tirzepatide also acts on a second hormone receptor, GIP) act on appetite and satiety pathways in the brain and slow how fast the stomach empties. The result is less hunger, earlier fullness, and quieter food noise, so most people simply eat less without white-knuckling it. Neither Novo Nordisk nor Eli Lilly is affiliated with our clinic. If you want the fuller picture of how these medications behave, our guide to GLP-1 myths and facts is a good next stop.
The efficacy gap is real, but read the numbers carefully
Here is where people want a single scoreboard, and here is where honesty matters. In a pooled analysis of orlistat trials, people taking it lost about 2.9 kg more than those on placebo at one year, roughly a 3% edge over placebo once diet and lifestyle are accounted for. In the pivotal orlistat studies, 73% of patients lost more than 5% of their body weight versus 45% on placebo, and 41% lost more than 10% versus 21% on placebo. In people with type 2 diabetes the effect ran a little smaller. Over four years, more orlistat patients held onto a meaningful loss than placebo patients did. So it works. It is not nothing.
Ready to start?
$199 Skeptics' Trial, see if it works for you
One month of medical-grade compounded semaglutide, the $119 doctor review, and a free B-12/lipotropic injection. No long-term commitment.
Start the 30-day trialGLP-1 numbers sit in a different range. In the STEP 1 trial, once-weekly semaglutide produced a mean body-weight change of about 14.9% at 68 weeks versus 2.4% on placebo. Tirzepatide in the SURMOUNT-1 trial reached mean reductions from roughly 15% up to the low twenties percent across its doses, and a head-to-head study found tirzepatide ahead of semaglutide, about 20% versus 14%. Those figures are large, and clearly larger than orlistat's.
One caution so you are not misled: the orlistat 3% is a placebo-subtracted figure, while the widely quoted 14.9% for semaglutide is a total average change, closer to about 12% once you subtract placebo the same way. Lining up 3% against 14.9% overstates an already real gap. And these numbers come from separate trials with different patients and study designs, not one head-to-head comparison, so treat it as a general contrast rather than a precise ratio. Even measured fairly, the GLP-1 medications come out ahead by a wide margin. If you are curious what those percentages translate to on the scale, we walk through it in how much weight you can lose on a GLP-1.
What orlistat actually feels like
Orlistat's side effects are not mysterious; they are the mechanism showing up in your bathroom. Because unabsorbed fat has to go somewhere, the common complaints are oily or fatty stools, oily spotting, gas with discharge, sudden bowel urgency, and, for some people, accidents. These effects are worst after a high-fat meal, which is exactly why the medication is meant to be paired with a genuinely low-fat, reduced-calorie diet. There is an upside: the discomfort tends to ease over the first few weeks, and it is somewhat self-correcting, since a greasy meal produces an unpleasant reminder. For a certain kind of person, that feedback is oddly motivating. For many others, it is a dealbreaker.
GLP-1 side effects are different in character, usually nausea, early fullness, or constipation as your body adjusts. We weigh the oral-versus-injection trade-off in our comparison of semaglutide versus phentermine, which is worth a look if you are torn between a pill and a shot.
The vitamin detail people forget
Because orlistat reduces fat absorption, it can also reduce absorption of the vitamins that travel with fat: A, D, E, K, and beta-carotene. The product labeling advises taking a daily multivitamin that contains these and spacing it well away from the medication, at least two hours before or after, which is why many people take it at bedtime. If you already run low on any of these vitamins, that is a conversation to have with your prescriber before you start. It is a small habit, but quietly skipping it for months is not trivial.
The less common but serious risks
Most orlistat problems are the digestive nuisances above, but the label also documents rarer, more serious ones: uncommon cases of severe liver injury, and kidney stones related to oxalate, including instances of oxalate-driven kidney injury. The over-the-counter version carries a required warning about kidney-stone and kidney risk. These are not reasons to panic, and they are uncommon, but they are a good reminder that available without a prescription does not mean free of consequences. Any weight-loss medication deserves a real medical conversation, which is part of why we screen carefully; see who qualifies for a GLP-1 for how that evaluation works.
Who might still choose orlistat
None of this makes orlistat obsolete. It has genuine advantages for the right person. It is an oral pill, not an injection. It barely enters the bloodstream, which some patients find reassuring. It is generally lower in cost, and it is the only weight-loss drug you can buy over the counter, sold as Alli 60 mg, while the prescription strength, Xenical 120 mg, has been available for years. For someone who cannot or would rather not use an injectable, who does not have access to a GLP-1, or who is genuinely willing to commit to a low-fat diet, orlistat can be a reasonable tool. Cost and access are real concerns, and for some people compounded semaglutide or tirzepatide enters that conversation too; those compounded versions are not FDA-approved and not brand-identical, and results vary by individual, so they deserve the same careful discussion as any other option.
What they have in common
For all their differences, both of these are labeled the same way where it counts: as an addition to a reduced-calorie diet and more physical activity, not a replacement for it. Orlistat literally requires a low-fat diet to work well and to be tolerable at all. GLP-1 medications make eating less feel achievable, but the weight that comes off and stays off still rides on lasting changes in how you eat and move. Neither one is a standalone fix, and any honest comparison ends there. The better question is usually not which drug is stronger, but which approach fits your body, your budget, and the life you can actually keep up. That is the conversation to have with a clinician who looks at your whole picture, not just the number on the box.
Frequently asked questions
Is orlistat as effective as Ozempic or Wegovy for weight loss?
No, and it is not close. In its trials, orlistat added roughly a 3% weight-loss edge over placebo at one year, while semaglutide in the STEP 1 trial showed a mean total change near 14.9% (about 12% after subtracting placebo), and tirzepatide reached the low twenties percent. These come from separate studies, not a single head-to-head trial, so treat it as a general comparison. Ozempic and Wegovy are semaglutide (Novo Nordisk); we are not affiliated. The gap is real, but orlistat can still suit specific patients, so the right choice depends on your situation and prescriber's judgment.
Can I really buy orlistat over the counter?
Yes. Alli is a lower-strength orlistat sold over the counter, and it is the only weight-loss drug available without a prescription in the United States. A higher-strength prescription version, Xenical, also exists. Over-the-counter access does not mean it is free of side effects or risks; the nonprescription label carries a warning about kidney-stone and kidney risk, and the digestive side effects apply to both. It is still worth discussing with a clinician before you start.
Why does orlistat cause oily stools?
Because that is the mechanism working. Orlistat blocks about 30% of the fat in a meal from being absorbed, and that unabsorbed fat has to leave the body, which produces oily or fatty stools, oily spotting, gas with discharge, and urgency. The effects are worst after high-fat meals and tend to ease over the first few weeks. Pairing the medication with a genuinely low-fat diet both improves results and reduces these symptoms.
Do I need to take vitamins if I use orlistat?
The product labeling advises it. Because orlistat lowers fat absorption, it can also lower absorption of the fat-soluble vitamins A, D, E, K, and beta-carotene. The label recommends a daily multivitamin containing these, taken at least two hours apart from the medication, which is why many people take it at bedtime. If you already have a known deficiency, raise it with your prescriber before starting rather than deciding on your own.
Which is better for me, orlistat or a GLP-1?
There is no universal answer, and neither is a fix on its own. GLP-1 medications produce much larger average weight loss and work by reducing appetite, but they are injectable and cost more. Orlistat is an oral, non-systemic, lower-cost option that may fit someone who cannot use or access a GLP-1 and is willing to eat a low-fat diet, though its digestive side effects are a real trade-off. Both are meant to be paired with reduced-calorie eating and activity. The honest way to decide is a full evaluation with a clinician, which is exactly what a visit is for.
This article is informational only and not medical advice. Speak with a licensed physician before starting or changing any GLP-1 therapy. Individual results vary. New Hope Weight Loss is a physician-supervised medical weight loss clinic in Costa Mesa, CA. Eligibility for treatment is determined during the medical consultation. Compounded semaglutide and compounded tirzepatide are not the same products as Wegovy®, Ozempic®, Mounjaro®, or Zepbound®.